Central Precocious Puberty: Treatment with Triptorelin 11.25 mg

Background. Few data are available on quarterly 11.25 mg GnRH analog treatment in central precocious puberty (CPP). Aim. To assess the efficacy of triptorelin 11.25 mg in children with CPP. Patients. 17 patients (16 females) with CPP (7.9 ± 0.9 years) were treated with triptorelin 11.25 mg/90 days....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chiocca, Elena, Dati, Eleonora, Baroncelli, Giampiero I., Cassio, Alessandra, Wasniewska, Malgorzata, Galluzzi, Fiorella, Einaudi, Silvia, Cappa, Marco, Russo, Gianni, Bertelloni, Silvano
Formato: Artigo
Idioma:Inglês
Publicado em: The Scientific World Journal 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3356708/
https://ncbi.nlm.nih.gov/pubmed/22645436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/2012/583751
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados